GEROADX

Our goal is to ensure timely access to our early diagnostic test for diverse populations around the world, in order to mitigate the negative impacts of this disease and improve the quality of life of patients and their caregivers... We are a clinical diagnostics company focused on Alzheimer's Disease. We will enter the initial markets during 2024. We have developed an innovative saliva-based test as an aid in the diagnosis of Alzheimer's disease and Mild Cognitive Impairment associated with Alzheimer's Disease